Trial Details

Not Recruiting
Basic Information
Clinical ID c5668
Identifier NL-OMON52357
Trial Title A Combined Phase 2/3 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis. - AMT-101-201
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions inflammatory bowel disease Pouchitis;10017969
Interventions AMT-101: Once daily by mouth in the morning approximately 30 minutes before breakfast for 12 weeks.Matching placebo: Once daily by mouth in the morning approximately 30 minutes before breakfast for 12 weeks.The first dose of study treat
Participant Information
Sponsor Applied Molecular Transport Inc.
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement ADULT
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL